Increasing gap junctional coupling: a tool for dissecting the role of gap junctions. 2007

Lene Nygaard Axelsen, and Ketil Haugan, and Martin Stahlhut, and Anne-Louise Kjølbye, and James K Hennan, and Niels-Henrik Holstein-Rathlou, and Jørgen Søberg Petersen, and Morten Schak Nielsen
Zealand Pharma A/S, 2600, Glostrup, Denmark.

Much of our current knowledge about the physiological and pathophysiological role of gap junctions is based on experiments where coupling has been reduced by either chemical agents or genetic modification. This has brought evidence that gap junctions are important in many physiological processes. In a number of cases, gap junctions have been implicated in the initiation and progress of disease, and experimental uncoupling has been used to investigate the exact role of coupling. The inverse approach, i.e., to increase coupling, has become possible in recent years and represents a new way of testing the role of gap junctions. The aim of this review is to summarize the current knowledge obtained with agents that selectively increase gap junctional intercellular coupling. Two approaches will be reviewed: increasing coupling by the use of antiarrhythmic peptide and its synthetic analogs and by interfering with the gating of gap junctional channels.

UI MeSH Term Description Entries
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010006 Osteoblasts Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone. Osteoblast
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D002450 Cell Communication Any of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals carried by neurotransmitter substances, hormones, and cyclic AMP. Cell Interaction,Cell-to-Cell Interaction,Cell Communications,Cell Interactions,Cell to Cell Interaction,Cell-to-Cell Interactions,Communication, Cell,Communications, Cell,Interaction, Cell,Interaction, Cell-to-Cell,Interactions, Cell,Interactions, Cell-to-Cell
D005260 Female Females
D006706 Homeostasis The processes whereby the internal environment of an organism tends to remain balanced and stable. Autoregulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D001145 Arrhythmias, Cardiac Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. Arrhythmia,Arrythmia,Cardiac Arrhythmia,Cardiac Arrhythmias,Cardiac Dysrhythmia,Arrhythmia, Cardiac,Dysrhythmia, Cardiac

Related Publications

Lene Nygaard Axelsen, and Ketil Haugan, and Martin Stahlhut, and Anne-Louise Kjølbye, and James K Hennan, and Niels-Henrik Holstein-Rathlou, and Jørgen Søberg Petersen, and Morten Schak Nielsen
March 1999, Journal of neurophysiology,
Lene Nygaard Axelsen, and Ketil Haugan, and Martin Stahlhut, and Anne-Louise Kjølbye, and James K Hennan, and Niels-Henrik Holstein-Rathlou, and Jørgen Søberg Petersen, and Morten Schak Nielsen
January 2001, Cell communication & adhesion,
Lene Nygaard Axelsen, and Ketil Haugan, and Martin Stahlhut, and Anne-Louise Kjølbye, and James K Hennan, and Niels-Henrik Holstein-Rathlou, and Jørgen Søberg Petersen, and Morten Schak Nielsen
January 2021, Frontiers in cellular neuroscience,
Lene Nygaard Axelsen, and Ketil Haugan, and Martin Stahlhut, and Anne-Louise Kjølbye, and James K Hennan, and Niels-Henrik Holstein-Rathlou, and Jørgen Søberg Petersen, and Morten Schak Nielsen
October 2013, Journal of neuroscience methods,
Lene Nygaard Axelsen, and Ketil Haugan, and Martin Stahlhut, and Anne-Louise Kjølbye, and James K Hennan, and Niels-Henrik Holstein-Rathlou, and Jørgen Søberg Petersen, and Morten Schak Nielsen
May 2014, Nature reviews. Neuroscience,
Lene Nygaard Axelsen, and Ketil Haugan, and Martin Stahlhut, and Anne-Louise Kjølbye, and James K Hennan, and Niels-Henrik Holstein-Rathlou, and Jørgen Søberg Petersen, and Morten Schak Nielsen
February 2000, Experimental cell research,
Lene Nygaard Axelsen, and Ketil Haugan, and Martin Stahlhut, and Anne-Louise Kjølbye, and James K Hennan, and Niels-Henrik Holstein-Rathlou, and Jørgen Søberg Petersen, and Morten Schak Nielsen
May 2010, Journal of neuroscience methods,
Lene Nygaard Axelsen, and Ketil Haugan, and Martin Stahlhut, and Anne-Louise Kjølbye, and James K Hennan, and Niels-Henrik Holstein-Rathlou, and Jørgen Søberg Petersen, and Morten Schak Nielsen
January 2018, Methods in molecular biology (Clifton, N.J.),
Lene Nygaard Axelsen, and Ketil Haugan, and Martin Stahlhut, and Anne-Louise Kjølbye, and James K Hennan, and Niels-Henrik Holstein-Rathlou, and Jørgen Søberg Petersen, and Morten Schak Nielsen
November 1993, Science (New York, N.Y.),
Lene Nygaard Axelsen, and Ketil Haugan, and Martin Stahlhut, and Anne-Louise Kjølbye, and James K Hennan, and Niels-Henrik Holstein-Rathlou, and Jørgen Søberg Petersen, and Morten Schak Nielsen
September 2021, Cells,
Copied contents to your clipboard!